Probing the Antitumor Mechanism of L. Aqueous Extract against Human Breast Cancer MCF7 Cells.

Bioengineering (Basel)

Drug Discovery and Development Research Group, College of Pharmacy and Nutrition, University of Saskatchewan, Saskatoon, SK S7N 5E5, Canada.

Published: December 2019

L. is one of the major medicinal plants used to treat cancer. However, the functional mechanism of L. extract is still unknown in spite of numerous studies on its active components. In this study, we probed the potential anticancer mechanism of the aqueous extract of L. (AESN) towards human breast cancer cell line MCF7. At a concentration of 10 g/L, AESN caused 43% cytotoxicity, inhibited the migration, and suppressed the activities of hexokinase and pyruvate kinase by about 30% and 40%, respectively, towards the MCF7 cells. RT-PCR analysis of a panel of 89 caner-related genes identified 13 upregulated and eight downregulated genes (>2-folds) in MCF7 cells upon AESN treatment. Gene ontology (GO) and functional disease ontology (FunDO) analyses show that the antitumor function of L. involves multiple genes and these genes are shared across other diseases or disorders.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6955812PMC
http://dx.doi.org/10.3390/bioengineering6040112DOI Listing

Publication Analysis

Top Keywords

mcf7 cells
12
mechanism aqueous
8
aqueous extract
8
human breast
8
breast cancer
8
probing antitumor
4
antitumor mechanism
4
extract human
4
mcf7
4
cancer mcf7
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!